Julio F Serrano - Publications
Affiliations: | University of Illinois, Urbana-Champaign, Urbana-Champaign, IL |
Year | Citation | Score | |||
---|---|---|---|---|---|
2021 | Gilchrist AE, Serrano JF, Ngo MT, Hrnjak Z, Kim S, Harley BAC. Encapsulation of murine hematopoietic stem and progenitor cells in a thiol-crosslinked maleimide-functionalized gelatin hydrogel. Acta Biomaterialia. PMID 34161871 DOI: 10.1016/j.actbio.2021.06.028 | 0.533 | |||
2020 | Zambuto SG, Serrano JF, Vilbert AC, Lu Y, Harley BAC, Pedron S. Response of neuroglia to hypoxia-induced oxidative stress using enzymatically crosslinked hydrogels. Mrs Communications. 10: 83-90. PMID 32719734 DOI: 10.1557/Mrc.2019.159 | 0.439 | |||
2019 | Serrano JF, Lee J, Daniel Curet L, Hagler LD, Bonson SE, Schuster EJ, Zimmerman SC. Development of novel macrocyclic small molecules that target CTG trinucleotide repeats. Bioorganic & Medicinal Chemistry. PMID 31113691 DOI: 10.1016/J.Bmc.2019.05.022 | 0.522 | |||
2019 | Lee J, Bai Y, Chembazhi UV, Peng S, Yum K, Luu LM, Hagler LD, Serrano JF, Chan HYE, Kalsotra A, Zimmerman SC. Intrinsically cell-penetrating multivalent and multitargeting ligands for myotonic dystrophy type 1. Proceedings of the National Academy of Sciences of the United States of America. PMID 30975744 DOI: 10.1073/Pnas.1820827116 | 0.54 | |||
2015 | Nguyen L, Luu LM, Peng S, Serrano JF, Chan HY, Zimmerman SC. Rationally Designed Small Molecules That Target Both the DNA and RNA Causing Myotonic Dystrophy Type 1. Journal of the American Chemical Society. PMID 26473464 DOI: 10.1021/Jacs.5B09266 | 0.576 | |||
Show low-probability matches. |